mittyri
★★  

Russia,
2013-11-01 09:30
(4208 d 09:13 ago)

Posting: # 11854
Views: 10,121
 

 Capecitabine: 2 slopes [PK / PD]

Dear All,

I would ask you about the concentration/time curve in capecitabine study.
Here's an example from M. Mackean et al. "Phase I and Pharmacologic Study of Intermittent Twice-Daily Oral Therapy With Capecitabine in Patients With Advanced and/or Metastatic Cancer" Journal of Clinical Oncology, Vol 16, No 9, 1998: pp 2977-2985
[image]

As you can see capecitabine and 5-FU curves have 2 slopes. What is the reason of such curve shapes? fed condition or something else?
In our study we have similar results.


Edit: Category changed. [Helmut]

Kind regards,
Mittyri
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2013-11-01 16:11
(4208 d 02:32 ago)

@ mittyri
Posting: # 11856
Views: 8,267
 

 Enterohepatic recirculation

Hi Miityri,

❝ As you can see capecitabine and 5-FU curves have 2 slopes. What is the reason of such curve shapes?


Capecitabine is partly excreted unchanged into the bile and known to undergo enterohepatic recirculation; such profiles are common.

Capecitabine → 5’-dFCR → 5’-dFUR → 5-FU → DHFU → FUPA → FBAL

Note that the primary metabolite 5’-dFCR does not show first-order elimination between 1–4 hours as well (concave semilog-plot). Cmax of the secondary 5’-dFUR is actually due to the reabsorbed fraction. If you walk the metabolization-chain further ‘downstream’ peaks merge and are shifted to later times.

❝ fed condition or something else?


See above – but in fasting state you would see a shift of the second peak towards later times (emptying of the gall bladder triggered by food). However, administration after food is the labeled use of Xeloda.

❝ In our study we have similar results.


As expected. Nothing to worry about in BE (that’s the drug, not the formulation).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
mittyri
★★  

Russia,
2013-11-21 13:23
(4188 d 05:20 ago)

@ Helmut
Posting: # 11934
Views: 6,364
 

 Enterohepatic recirculation

Hi Helmut,

Thank you for exhaustive explanation!
The information from this forum is very helpful.

I've one more question following up upon this topic.

One of the subjects has actual data:
[image]

All points are BQL after last visible point.
So the question is: how to calculate the AUC part from tlast to infinity in this case with Winnonlin (what kind of points to collect for lambda z calculation & hl)?

Kind regards,
Mittyri
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2013-11-21 15:18
(4188 d 03:25 ago)

@ mittyri
Posting: # 11936
Views: 6,912
 

 WinNonlin: λz

Hi Mittyri,

❝ So the question is: how to calculate the AUC part from tlast to infinity in this case with Winnonlin (what kind of points to collect for lambda z calculation & hl)?


What did you state in the protocol?
  • Generally it is not a good idea to include Cmax/tmax in the estimation of λz, since absorption is not complete. That’s the reason why Phoenix’ default “Best Fit” would not give you an estimate (only two data points >tmax). On the other hand WinNonlin ≤5.3 would happily give you an R²adj of ~0.999 – in log-scale the last part of the profile looks nice.

    [image]

  • Some ideas:
    • Overrule Phoenix’ default and use the last three data points. You could justify that by the almost identical λz obtained from the last two.
    • According to the Russian GL the main PK metric for extent of absorption is AUCt (if AUCt > 80% AUC). If you cannot demonstrate that according to the protocol (e.g., three data points after tmax required), consider excluding the subject from the com­parison of AUCt. That should no hurt in terms of power because the critical PK metric is Cmax (likely higher CV).
PS: Excel’s xy-plot with the “smooth line” option sucks.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
mittyri
★★  

Russia,
2013-11-22 09:25
(4187 d 09:18 ago)

@ Helmut
Posting: # 11941
Views: 6,266
 

 WinNonlin: λz

Hi Helmut,

Thank you for advice!

❝ What did you state in the protocol?


I didn't state in the protocol anything about this situation. Now I have a plan&experience ;-)

Could you give a cue in the same situation:
[image]

Last point is BLQ.

What do you think about this case? How to calculate λz?

Kind regards,
Mittyri
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
120 visitors (0 registered, 120 guests [including 5 identified bots]).
Forum time: 19:44 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5